Nosopharm and GNA Now announce positive results for the late

Nosopharm and GNA Now announce positive results for the late preclinical development of the first-in

An important milestone has been reached for the GNA NOW Consortium with the completion of the GLP toxicology studies for the NOSO-502 program. The results allow for the further development of the program to Phase 1 Utrecht, the Netherlands, and Lyon, France, 8 June 2022 – Nosopharm, a biotechnology company specializ...

Related Keywords

Germany , Hamburg , Schmallenberg , Nordrhein Westfalen , Paris , France General , France , Netherlands , Frankfurt , Brandenburg , Poitiers , Poitou Charentes , Rotterdam , Zuid Holland , Vienna , Wien , Austria , Dublin , Ireland , French , German , , Fraunhofer Institute For Molecular Biology , University Of Poitiers , Erasmus Mc University Medical Center Rotterdam , Technology Research Institute , European Federation Of Pharmaceutical Industries , Innovative Medicines Initiative , University Of Liverpool , Research Unit , European Consortium , University Campus Of Poitiers France , French Ministry Of Defense , European Union , Innovative Health Initiative , European Union Horizon , Department Of Clinical , World Health Organization , Department Of Clinical Pharmacology , Bristol National Health Service , German Center , Infection Research , Institute Of Translational Medicine , Centre For Antimicrobial Pharmacodynamics , Consortium Gram , Helmholtz Association , Catholic University Of Louvain , University Of Vienna , Helmholtz Centre For Infection Research , Clinical Trial Authorization , Philippe Villain Guillot , Gram Negative Antibacterials , European Federation , Pharmaceutical Industries , Lynn Silver , Investigational New Drug , France Relance , French Ministry , Region Languedoc Roussillon , Helmholtz Centre , Microbiology Research Department , North Bristol National Health Services Trust , Quality Management , Quality Management Template , Public Involvement , Practical Guide , Antimicrobial Pharmacodynamics , Molecular Pharmacology , Translational Medicine , University Campus , Region Nouvelle Aquitaine , Paris Sud , Paris Diderot , Catholic University , Medical Center , Western Europe , Medical Microbiology , Infectious Diseases , Medical University , Clinical Pharmacology , Fraunhofer Institute , Molecular Biology , Applied Ecology , Clinical Pipeline , Drug Resistant Bacterial Infections ,

© 2025 Vimarsana